Squamous cell carcinoma of the skin: clinical pattern and challenges of treatment

Squamous cell carcinoma of the skin: clinical pattern and challenges of treatment In Nigeria, Tanzania and Togo, squamous cell carcinoma (SCC) is the commonest skin malignancy. This is in contrast with the Caucasians in Europe, North America and Australia where basal cell carcinoma accounts for 70–80% of skin cancer. Risk factors vary with race, geographic region and site of lesion. We present this study to highlight the clinical pattern, risk factors, challenges and outcome of management of this problem in our region. All patients with histologic diagnosis of squamous cell carcinoma that presented to the University of Calabar Teaching Hospital, Calabar from January 2005 to December 2009 were studied. In total, 38 patients (18 males, 20 females) whose ages ranged from 16 to 70 years (mean 44.8 years) were afflicted with SCC lesions. They accounted for 39.0% of skin malignancy and 5.7% of total malignancy. Kaposi sarcoma 33 (33%) ranked second while malignant melanoma 11 (11%) was third. The ages of the eight albinos (four males, four females) recorded ranged between 21 and 30 years (mean 24.3 years). The ages of the 30 blacks (14 males, 16 females) ranged from 16 to 70 years (mean 50.2 years). The lower limb was the commonest afflicted site recorded in 15 (39.0%) patients. The head and neck ranked second with 14 (37.0%) patients while the anogenital region with eight (21%) patients ranked third. Marjolin’s ulcer recorded in 14 (36.8%) patients afflicted only the limbs. The results were satisfactory in 13 (34%) patients, while in 21 (55%) patients, the outcome was poor, and hospital mortality was recorded in four (11%) patients. Squamous cell carcinoma is largely preventable, late presentation with advanced lesion was a major underlying issue. Early institution of preventive strategies, early presentation and proper surgical evaluation of chronic ulcers would improve outcome. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Plastic Surgery Springer Journals

Squamous cell carcinoma of the skin: clinical pattern and challenges of treatment

Loading next page...
Copyright © 2011 by Springer-Verlag
Medicine & Public Health; Plastic Surgery
Publisher site
See Article on Publisher Site


  • Skin malignancy of the head and neck in Calabar, Southern Nigeria
    Asuquo, ME; Otei, OO; Umana, A; Bassey, I; Ebughe, G
  • Cutaneous squamous cell carcinoma in Calabar, southern Nigeria
    Asuquo, ME; Udosen, AM; Ikpeme, IA; Ngim, NE; Otei, OO; Ebughe, G; Bassey, EE

You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial